These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9105265)

  • 1. Interference with testing for lysergic acid diethylamide.
    Ritter D; Cortese CM; Edwards LC; Barr JL; Chung HD; Long C
    Clin Chem; 1997 Apr; 43(4):635-7. PubMed ID: 9105265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
    Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
    J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the diagnostic performance of the Boehringer Mannheim CEDIA LSD assay.
    Verstraete AG; Steyaert S
    J Anal Toxicol; 1998; 22(7):601-4. PubMed ID: 9847012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of lysergic acid diethylamide in human urine: elimination, screening and analytical confirmation].
    Vu-Duc T; Vernay A; Calanca A
    Schweiz Med Wochenschr; 1991 Dec; 121(50):1887-90. PubMed ID: 1759150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development and application of a gas chromatography-mass spectrometric (GC-MS) assay to determine the presence of 2-oxo-3-hydroxy-LSD in urine.
    Burnley BT; George S
    J Anal Toxicol; 2003; 27(4):249-52. PubMed ID: 12820748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and interpretation of lysergic acid diethylamide results by immunoassay screening of urine in various testing groups.
    Wu AH; Feng YJ; Pajor A; Gornet TG; Wong SS; Forte E; Brown J
    J Anal Toxicol; 1997; 21(3):181-4. PubMed ID: 9171199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of lysergic acid diethylamide (LSD) in urine by gas chromatography-ion trap tandem mass spectrometry.
    Sklerov JH; Kalasinsky KS; Ehorn CA
    J Anal Toxicol; 1999 Oct; 23(6):474-8. PubMed ID: 10517553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of LSD and a major metabolite, 2-oxo-3-hydroxy-LSD, in human urine by solid-phase extraction and gas chromatography-tandem mass spectrometry.
    Reuschel SA; Percey SE; Liu S; Eades DM; Foltz RL
    J Anal Toxicol; 1999 Sep; 23(5):306-12. PubMed ID: 10488916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoassay analysis of lysergic acid diethylamide.
    Cody JT; Valtier S
    J Anal Toxicol; 1997 Oct; 21(6):459-64. PubMed ID: 9323526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoassay screening of lysergic acid diethylamide (LSD) and its confirmation by HPLC and fluorescence detection following LSD ImmunElute extraction.
    Grobosch T; Lemm-Ahlers U
    J Anal Toxicol; 2002 Apr; 26(3):181-6. PubMed ID: 11991536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD.
    Poch GK; Klette KL; Hallare DA; Manglicmot MG; Czarny RJ; McWhorter LK; Anderson CJ
    J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):23-33. PubMed ID: 10202954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LSD screening in urine performed by CEDIA® LSD assay: positive interference with sertraline.
    Citterio-Quentin A; Seidel E; Ramuz L; Parant F; Moulsma M
    J Anal Toxicol; 2012 May; 36(4):289-90. PubMed ID: 22511703
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of LSD in urine by capillary column gas chromatography and electron impact mass spectrometry.
    Francom P; Andrenyak D; Lim HK; Bridges RR; Foltz RL; Jones RT
    J Anal Toxicol; 1988; 12(1):1-8. PubMed ID: 3352236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-oxo-3-hydroxy-LSD: an important LSD metabolite?
    Verstraete AG; Van de Velde EJ
    Acta Clin Belg; 1999; 53 Suppl 1():94-6. PubMed ID: 10216992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gas chromatographic-electron-impact mass fragmentometric determination of lysergic acid diethylamide in urine.
    Paul BD; Mitchell JM; Burbage R; Moy M; Sroka R
    J Chromatogr; 1990 Jul; 529(1):103-12. PubMed ID: 2211923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a nonisotopic immunoassay for the detection of LSD in human urine.
    Cassells NP; Craston DH; Hand CW; Baldwin D
    J Anal Toxicol; 1996 Oct; 20(6):409-15. PubMed ID: 8889677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quantitation of 2-oxo-3-hydroxy lysergic acid diethylamide (O-H-LSD) in human urine specimens, a metabolite of LSD: comparative analysis using liquid chromatography-selected ion monitoring mass spectrometry and liquid chromatography-ion trap mass spectrometry.
    Poch GK; Klette KL; Anderson C
    J Anal Toxicol; 2000 Apr; 24(3):170-9. PubMed ID: 10774536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-MS analysis of 2-oxo-3-hydroxy LSD from urine using a Speedisk positive-pressure processor with Cerex PolyChrom CLIN II columns.
    Horn CK; Klette KL; Stout PR
    J Anal Toxicol; 2003 Oct; 27(7):459-63. PubMed ID: 14607000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An online immunoassay for LSD: comparison with GC-MS and the Abuscreen RIA.
    McNally AJ; Goc-Szkutnicka K; Li Z; Pilcher I; Polakowski S; Salamone SJ
    J Anal Toxicol; 1996 Oct; 20(6):404-8. PubMed ID: 8889676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of lysergic acid diethylamide (LSD) in urine by instrumental high-performance thin-layer chromatography.
    Blum LM; Carenzo EF; Rieders F
    J Anal Toxicol; 1990; 14(5):285-7. PubMed ID: 2263062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.